Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 24-Nov-2022
No. of pages: 122

Inhibitors of dipeptidyl peptidase 4, also DPP-4 inhibitors or gliptins, are a class of oral hypoglycemics that block the enzyme dipeptidyl peptidase-4 (DPP-4). They can be used to treat diabetes mellitus type 2.

The report focuses on the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market.

Major Players in the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market are:

Eli Lilly

GlaxoSmithKline

Pfizer

Merck

Bristol-Myers Squibb

Sanofi

Novo Nordisk

Takeda

Boehringer Ingelheim

AstraZeneca

On the basis of types, the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market is primarily split into:

Nesina

Tradjenta

Onglyza

Januvia

Others

On the basis of applications, the market covers:

Type 2 Diabetes

Others

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Overview
1.1 Product Overview and Scope of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market
1.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Segment by Type
1.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Segment by Application
1.3.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (2017-2029)
1.5.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry
1.7 Impact of Carbon Neutrality on the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry

2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Upstream and Downstream Analysis
2.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 Eli Lilly
3.1.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Performance (2017-2022)
3.1.4 Business Overview
3.2 GlaxoSmithKline
3.2.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Pfizer
3.3.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Merck
3.4.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Bristol-Myers Squibb
3.5.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Sanofi
3.6.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Novo Nordisk
3.7.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Takeda
3.8.1 Takeda Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Boehringer Ingelheim
3.9.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Performance (2017-2022)
3.9.4 Business Overview
3.10 AstraZeneca
3.10.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Performance (2017-2022)
3.10.4 Business Overview

4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Landscape by Player
4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Share by Player (2017-2022)
4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Player (2017-2022)
4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price by Player (2017-2022)
4.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Gross Margin by Player (2017-2022)
4.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Competitive Situation and Trends
4.5.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Concentration Rate
4.5.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price Trend by Type
5.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Type (2017-2022)
5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Type (2017-2022)
5.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type (2017-2022)
5.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Growth Rate of Nesina (2017-2022)
5.4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Growth Rate of Tradjenta (2017-2022)
5.4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Growth Rate of Onglyza (2017-2022)
5.4.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Growth Rate of Januvia (2017-2022)
5.4.5 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Growth Rate of Others (2017-2022)

6 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Analysis by Application
6.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption and Market Share by Application (2017-2022)
6.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption and Growth Rate of Type 2 Diabetes (2017-2022)
6.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption and Growth Rate of Others (2017-2022)

7 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue Region Wise (2017-2022)
7.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share, Region Wise (2017-2022)
7.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2022-2029)
8.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue Forecast (2022-2029)
8.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price and Trend Forecast (2022-2029)
8.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.3 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.5 India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Revenue Forecast (2022-2029)
8.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate of Nesina (2022-2029)
8.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate of Tradjenta (2022-2029)
8.3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate of Onglyza (2022-2029)
8.3.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate of Januvia (2022-2029)
8.3.5 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate of Others (2022-2029)
8.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption Forecast by Application (2022-2029)
8.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption Value and Growth Rate of Type 2 Diabetes (2022-2029)
8.4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption Value and Growth Rate of Others (2022-2029)
8.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast Under COVID-19

9 Industry Outlook
9.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Drivers Analysis
9.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Restraints and Challenges
9.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Antidiabetic Sulphonylureas Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 02-Feb-2023        Price: US 3450 Onwards        Pages: 112
    The report focuses on the Antidiabetic Sulphonylureas market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream marke......
  • Global Lixisenatide Market Research Report 2023
    Published: 01-Feb-2023        Price: US 2900 Onwards        Pages: 71
    Highlights The global Lixisenatide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Lixisenatide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. Asia-Paci......
  • Global Incretin-Based Drugs Market Research Report 2023
    Published: 31-Jan-2023        Price: US 2900 Onwards        Pages: 87
    Highlights The global Incretin-Based Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Incretin-Based Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Incretin-Based Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 31-Jan-2023        Price: US 3450 Onwards        Pages: 102
    The report focuses on the Incretin-Based Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. More......
  • Global Repaglinide Market Research Report 2023
    Published: 30-Jan-2023        Price: US 2900 Onwards        Pages: 94
    Repaglinide is a benzoic acid derivative and is used in the therapy of type 2 diabetes. Highlights The global Repaglinide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Repaglinide is estimated to increase from $ million in 2023 to reach $ mill......
  • Global Antidiabetics Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 26-Jan-2023        Price: US 3450 Onwards        Pages: 111
    The report focuses on the Antidiabetics market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, c......
  • Global Pioglitazone Hydrochloride Market Research Report 2023
    Published: 26-Jan-2023        Price: US 2900 Onwards        Pages: 98
    The global Pioglitazone Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Pioglitazone Hydrochloride is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. Asia......
  • Global Antidiabetic Biguanides Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 26-Jan-2023        Price: US 3450 Onwards        Pages: 107
    The report focuses on the Antidiabetic Biguanides market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. M......
  • Global Glucagon Like Peptide-1 (Glp-1) Agonists Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 24-Jan-2023        Price: US 3450 Onwards        Pages: 114
    The report focuses on the Glucagon Like Peptide-1 (Glp-1) Agonists market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the dow......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs